This finding could be relevant for oral cancer immunoprevention, as IL17 signaling is emerging as a potent immunosuppressive mechanism that promotes resistance to immune checkpoint blockade, although the mechanisms underlying these effects are still poorly understood [42]. This evidence concerns the gene IL17A and lip and oral cavity carcinoma.